Национальный Медицинский Университет Им. А.А. Богомольца
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Национальный Медицинский Университет Им. А.А. БогомольцаfiledCriticalНациональный Медицинский Университет Им. А.А. Богомольца
Priority to UAU201314938UpriorityCriticalpatent/UA89772U/en
Publication of UA89772UpublicationCriticalpatent/UA89772U/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The method for treating the measles in the children provides for the symptomatic therapy supplemented with homeopathic drug Influcide. The dose in the children aged from 1 to 12 years is one tablet every 2 hours (not more than 8 tablets daily) until the improvement of the patient's condition (for the first 2-3 days of the treatment), then one tablet thrice a day. The dose for the children aged over 12 years is one tablet every one hour (not more than 12 tablets daily) until the improvement of the patient's condition (for the first 2-3 days of the treatment), then one tablet thrice a day for 7-10 days. In the children aged over 12 years, Influcide is administered also as a solution at a dose of 10 drops every hour (not more than 12 times a day) until the improvement of the patient's condition (for the first 2-3 days of the treatment), then 10 drops thrice a day for 7-10 days.
UAU201314938U2013-12-202013-12-20Method for treating measles in children
UA89772U
(en)